retatrutide targets Dosing Guide: 1-12 mg Weekly Triple Agonist (2026) Retatrutide for Weight Loss: TRIUMPH-1

Short answer VA and TRICARE GLP-1 coverage in 2026: who qualifies for Wegovy or Zepbound, CHAMPVA rules, whether active duty can take GLP-1s, and what to do if denied

micro-dosing resets this gradually

No adjustments, no extrasjust a one-size-fits-all, easy-to-use product

Phase 3: Ongoing, comparing retatrutide with placebo for long-term safety and effectiveness in large groups

Intranasal administration through the olfactory pathway could enable researchers to investigate retatrutide effects on brain GLP-1, GIP, and glucagon receptors without the confounding variable of high peripheral peptide levels

Glucagon-receptor activation contributes effects on hepatic lipid metabolism and whole-body energy expenditure that are absent from GLP-1 mono-agonists and dual GLP-1/GIP agonists